Carol R. DiRaimondo

656 total citations
9 papers, 491 citations indexed

About

Carol R. DiRaimondo is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Carol R. DiRaimondo has authored 9 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Physiology and 2 papers in Surgery. Recurrent topics in Carol R. DiRaimondo's work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Alzheimer's disease research and treatments (5 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Carol R. DiRaimondo is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Alzheimer's disease research and treatments (5 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Carol R. DiRaimondo collaborates with scholars based in United States. Carol R. DiRaimondo's co-authors include William J. Stone, Terence T. Casey, Peter D. Gorevic, Frances Prelli, B Frangione, Victor E. Pollak, Merlyn M. Rodrigues, Blas Frangione, M. D. Poulik and Priscilla C. Munoz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and American Journal of Kidney Diseases.

In The Last Decade

Carol R. DiRaimondo

9 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol R. DiRaimondo United States 6 304 244 176 64 52 9 491
Hannelore Hampl Germany 11 143 0.5× 135 0.6× 140 0.8× 44 0.7× 43 0.8× 19 381
Maria Wanic-Kossowska Poland 12 83 0.3× 55 0.2× 146 0.8× 72 1.1× 41 0.8× 47 452
Alan W. Hodson United Kingdom 10 173 0.6× 134 0.5× 54 0.3× 101 1.6× 28 0.5× 32 550
Helen Rodela Canada 14 68 0.2× 88 0.4× 324 1.8× 168 2.6× 47 0.9× 26 595
M. Ketteler Germany 6 119 0.4× 65 0.3× 205 1.2× 40 0.6× 66 1.3× 8 355
Takashi Ioka Japan 10 76 0.3× 51 0.2× 174 1.0× 47 0.7× 52 1.0× 15 377
Jose A. Arruda Brazil 12 171 0.6× 44 0.2× 105 0.6× 140 2.2× 11 0.2× 29 427
Glynda G. Gerron United States 10 193 0.6× 78 0.3× 48 0.3× 43 0.7× 41 0.8× 12 456
Kaori Kanegae Japan 8 55 0.2× 74 0.3× 193 1.1× 62 1.0× 22 0.4× 11 343
L. Lecavalier Canada 9 63 0.2× 108 0.4× 39 0.2× 70 1.1× 31 0.6× 11 355

Countries citing papers authored by Carol R. DiRaimondo

Since Specialization
Citations

This map shows the geographic impact of Carol R. DiRaimondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol R. DiRaimondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol R. DiRaimondo more than expected).

Fields of papers citing papers by Carol R. DiRaimondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol R. DiRaimondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol R. DiRaimondo. The network helps show where Carol R. DiRaimondo may publish in the future.

Co-authorship network of co-authors of Carol R. DiRaimondo

This figure shows the co-authorship network connecting the top 25 collaborators of Carol R. DiRaimondo. A scholar is included among the top collaborators of Carol R. DiRaimondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol R. DiRaimondo. Carol R. DiRaimondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
DiRaimondo, Carol R. & Victor E. Pollak. (1993). Bioincompatibility Plays a Major Role in β2‐Microglobulin Amyloidosis. Seminars in Dialysis. 6(3). 192–196. 3 indexed citations
2.
DiRaimondo, Carol R. & Victor E. Pollak. (1989). β2-Microglobulin Kinetics in Maintenance Hemodialysis: A Comparison of Conventional and High-Flux Dialyzers and the Effects of Dialyzer Reuse. American Journal of Kidney Diseases. 13(5). 390–395. 34 indexed citations
3.
DiRaimondo, Carol R., Patricia McCarley, & William J. Stone. (1988). Beta-2 Microglobulin in Peritoneal Dialysis Patients: Serum Levels and Peritoneal Clearances. Peritoneal Dialysis International. 8(1). 43–47. 11 indexed citations
4.
Gorevic, Peter D., Priscilla C. Munoz, Terence T. Casey, et al.. (1986). Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.. Proceedings of the National Academy of Sciences. 83(20). 7908–7912. 127 indexed citations
5.
Gorevic, Peter D., Priscilla C. Munoz, Terence T. Casey, et al.. (1986). Dialysis related amyloidosis polymerization of beta 2 microglobulin in tissue. Clinical research. 34(2). 494. 1 indexed citations
6.
DiRaimondo, Carol R., et al.. (1986). Scapular fractures resulting from grand mal seizures in chronic hemodialysis patients.. PubMed. 79(7). 411–4. 4 indexed citations
7.
DiRaimondo, Carol R., et al.. (1986). Pathologic Fractures Associated with Idiopathic Amyloidosis of Bone in Chronic Hemodialysis Patients. ˜The œNephron journals/Nephron journals. 43(1). 22–27. 71 indexed citations
8.
Casey, Terence T., et al.. (1986). Tumoral amyloidosis of bone of beta2-microglobulin origin in association with long-term hemodialysis: A new type of amyloid disease. Human Pathology. 17(7). 731–738. 58 indexed citations
9.
Gorevic, Peter D., Terence T. Casey, William J. Stone, et al.. (1985). Beta-2 microglobulin is an amyloidogenic protein in man.. Journal of Clinical Investigation. 76(6). 2425–2429. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026